Bath & Body Works, INC. (BBWI) — SEC Filings
Latest SEC filings for Bath & Body Works, INC.. Recent 10-Q filing on Nov 20, 2025. AI-decoded analysis of earnings, risk factors, and insider trades.
View Bath & Body Works, INC. on SEC EDGAR
Overview
Bath & Body Works, INC. (BBWI) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Nov 20, 2025: Bath & Body Works, Inc. (BBWI) reported a decline in net income and net sales for the third quarter of 2025 compared to the prior year. Net sales decreased to $1,594 million from $1,610 million in Q3 2024, a 1% reduction. Net income saw a more significant drop, falling to $77 million in Q3 2025 from
Sentiment Summary
Across 36 filings, the sentiment breakdown is: 3 bearish, 33 neutral. The dominant filing sentiment for Bath & Body Works, INC. is neutral.
Filing Type Overview
Bath & Body Works, INC. (BBWI) has filed 6 10-Q, 15 8-K, 2 DEF 14A, 2 10-K, 9 SC 13G/A, 1 SC 13D/A, 1 SC 13G with the SEC between Jan 2024 to Nov 2025.
Filings by Year
Recent Filings (36)
-
BBWI Q3 Profit Plunges 27% Amidst Sales Dip
— 10-Q · Nov 20, 2025 Risk: medium
Bath & Body Works, Inc. (BBWI) reported a decline in net income and net sales for the third quarter of 2025 compared to the prior year. Net sales decreased to $ -
BBWI's Q2 Net Income Plunges 58% Despite Modest Sales Growth
— 10-Q · Aug 28, 2025 Risk: high
Bath & Body Works, Inc. (BBWI) reported a mixed financial performance for the second quarter ended August 2, 2025. Net sales increased slightly to $1,549 millio -
Bath & Body Works Files 8-K on Shareholder Votes
— 8-K · Jun 5, 2025 Risk: low
Bath & Body Works, Inc. filed an 8-K on June 5, 2025, to report on matters submitted to a vote of its security holders. The filing details the company's corpora -
Bath & Body Works Q1 Net Income Dips to $76M Amid Revenue Decline
— 10-Q · May 29, 2025 Risk: medium
Bath & Body Works, Inc. (BBWI) reported a net income of $76 million for the first quarter ended May 3, 2025, a decrease from $87 million in the prior-year perio -
Bath & Body Works Enters Material Definitive Agreement
— 8-K · May 22, 2025 Risk: medium
On May 22, 2025, Bath & Body Works, Inc. entered into a material definitive agreement related to a financial obligation. The company, formerly known as L Brands -
Bath & Body Works Files 8-K on Financials and Personnel Changes
— 8-K · May 19, 2025 Risk: medium
Bath & Body Works, Inc. filed an 8-K on May 19, 2025, reporting on results of operations and financial condition as of May 16, 2025. The filing also disclosed t -
Bath & Body Works Files DEF 14A on Executive Compensation
— DEF 14A · Apr 25, 2025 Risk: medium
Bath & Body Works, Inc. filed its DEF 14A on April 25, 2025, detailing executive compensation and corporate governance matters for the fiscal year ending Februa -
Bath & Body Works Files 8-K
— 8-K · Apr 17, 2025 Risk: low
Bath & Body Works, Inc. filed an 8-K on April 17, 2025, reporting on Regulation FD disclosures and financial statements. The filing confirms the company's princ -
Bath & Body Works Files 8-K
— 8-K · Mar 19, 2025 Risk: low
Bath & Body Works, Inc. filed an 8-K on March 19, 2025, reporting other events and financial statements. The company, formerly known as L Brands, Inc., is incor -
Bath & Body Works Files 2024 10-K
— 10-K · Mar 14, 2025 Risk: medium
Bath & Body Works, Inc. filed its 2024 10-K report on March 14, 2025, detailing its fiscal year ending February 1, 2025. The company, formerly known as L Brands -
Bath & Body Works Files 8-K
— 8-K · Mar 11, 2025 Risk: low
Bath & Body Works, Inc. filed an 8-K on March 11, 2025, to report on Regulation FD disclosures and file financial statements and exhibits. The filing does not c -
Bath & Body Works Files 8-K on Financials
— 8-K · Feb 27, 2025 Risk: low
Bath & Body Works, Inc. filed an 8-K on February 27, 2025, reporting on its results of operations and financial condition. The filing also included Regulation F -
Bath & Body Works Elects New Board Chair
— 8-K · Feb 3, 2025 Risk: low
Bath & Body Works, Inc. announced on February 3, 2025, that its Board of Directors elected Sarah Nash as the new Chair of the Board, effective January 31, 2025. -
Bath & Body Works Files 8-K
— 8-K · Jan 15, 2025 Risk: low
Bath & Body Works, Inc. filed an 8-K on January 15, 2025, reporting on Regulation FD disclosures and financial statements. The company, formerly known as L Bran -
Bath & Body Works Files Q3 2024 10-Q
— 10-Q · Nov 26, 2024 Risk: medium
Bath & Body Works, Inc. filed its 10-Q for the period ending November 2, 2024. The company reported its financial results for the third quarter of fiscal year 2 -
Bath & Body Works Files 8-K on Financials
— 8-K · Nov 25, 2024 Risk: low
Bath & Body Works, Inc. filed an 8-K on November 25, 2024, reporting on its results of operations and financial condition. The filing also includes Regulation F - SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- SC 13G/A Filing — SC 13G/A · Nov 4, 2024
-
Third Point LLC Amends Bath & Body Works Stake Filing
— SC 13D/A · Oct 25, 2024 Risk: medium
Third Point LLC, managed by Daniel S. Loeb, has amended its Schedule 13D filing regarding Bath & Body Works, Inc. on October 25, 2024. The filing indicates a ch - SC 13G/A Filing — SC 13G/A · Oct 7, 2024
-
Bath & Body Works Files 8-K on Leadership Changes
— 8-K · Sep 25, 2024 Risk: low
Bath & Body Works, Inc. filed an 8-K on September 25, 2024, reporting events as of September 23, 2024. The filing covers the departure of directors, election of -
Bath & Body Works Files Q2 2024 10-Q
— 10-Q · Aug 28, 2024 Risk: medium
Bath & Body Works, Inc. filed its 10-Q for the period ending August 3, 2024. The filing details financial performance and operational updates for the second qua -
Bath & Body Works Files 8-K on Shareholder Votes and Financials
— 8-K · Jun 27, 2024 Risk: low
On June 27, 2024, Bath & Body Works, Inc. filed an 8-K report detailing the submission of matters to a vote of security holders and the filing of financial stat -
Bath & Body Works Files Q1 2024 10-Q
— 10-Q · Jun 4, 2024 Risk: medium
Bath & Body Works, Inc. filed its 10-Q for the period ending May 4, 2024. The company reported its financial results for the first quarter of fiscal year 2024. -
Bath & Body Works, Inc. DEF 14A Filing
— DEF 14A · May 15, 2024 Risk: low
Bath & Body Works, Inc. (BBWI) filed a Proxy Statement (DEF 14A) with the SEC on May 15, 2024. Bath & Body Works, Inc. filed a DEF 14A on 2024-05-15. The filing -
Bath & Body Works Names New CEO and Board Chair
— 8-K · Apr 22, 2024 Risk: medium
Bath & Body Works, Inc. announced on April 22, 2024, that Sarah Nash will transition from Interim CEO to CEO, effective April 20, 2024. Concurrently, she will a -
Bath & Body Works, Inc. Files 2024 10-K Report
— 10-K · Mar 22, 2024 Risk: medium
Bath & Body Works, Inc. (BBWI) filed a Annual Report (10-K) with the SEC on March 22, 2024. Bath & Body Works, Inc. filed its annual report on Form 10-K for the -
Bath & Body Works Names New CEO, Restructures Legal Role
— 8-K · Mar 15, 2024 Risk: low
Bath & Body Works, Inc. announced on March 15, 2024, that Sarah Nash will transition from Interim CEO to CEO, effective March 13, 2024. Concurrently, Jeff Black -
Bath & Body Works Files 8-K on Financial Condition and Operations
— 8-K · Feb 29, 2024 Risk: low
Bath & Body Works, Inc. filed an 8-K on February 29, 2024, reporting on its results of operations and financial condition. The filing also included information - SC 13G/A Filing — SC 13G/A · Feb 22, 2024
- SC 13G Filing — SC 13G · Feb 14, 2024
- SC 13G/A Filing — SC 13G/A · Feb 14, 2024
-
Vanguard Amends BBWI Stake, Maintains Significant Passive Holding
— SC 13G/A · Feb 13, 2024 Risk: low
The Vanguard Group, a major investment firm, filed an updated SC 13G/A on February 13, 2024, indicating its ownership in Bath & Body Works Inc. (BBWI) as of Dec -
BlackRock Amends BBWI Stake, Remains Key Institutional Holder
— SC 13G/A · Jan 26, 2024
BlackRock Inc. filed an amended SC 13G/A on January 26, 2024, indicating its ownership in Bath & Body Works, Inc. (BBWI) as of December 31, 2023. This filing up
Risk Profile
Risk Assessment: Of BBWI's 27 recent filings, 1 were flagged as high-risk, 12 as medium-risk, and 14 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
Key financial metrics from Bath & Body Works, INC.'s most recent 10-Q filing (Nov 20, 2025):
- Revenue: $1,594M
- Net Income: $77M
- EPS: $0.37
- Debt-to-Equity: N/A
- Cash Position: $236M
- Operating Margin: 10.1%
- Total Assets: $4,989M
- Total Debt: $3,890M
Key Executives
- Gina Boswell
- Andrew Meslow
- Sarah Nash
- Leslie Wexner
- Daniel S. Loeb
- Joshua L. Targoff
- Wendy Arlin
- Jeff Black
Industry Context
Bath & Body Works operates in the personal care and home fragrance retail sector, a market characterized by strong brand loyalty and seasonal demand. The competitive landscape includes both direct competitors and a wide array of retailers offering similar products. Trends include a continued shift towards omnichannel sales and a focus on product innovation and sustainability.
Top Tags
corporate-governance (5) · Retail (4) · 10-Q (4) · financial-reporting (4) · leadership-change (4) · Consumer Discretionary (3) · filing (3) · disclosure (3) · 8-K (3) · retail (3)
Key Numbers
- Net Sales (Q3 2025): $1,594M — Decreased from $1,610M in Q3 2024
- Net Income (Q3 2025): $77M — Decreased from $106M in Q3 2024, a 27.36% decline
- Net Income (YTD 2025): $246M — Decreased from $345M in YTD 2024, a 28.7% decline
- Net Sales (YTD 2025): $4,567M — Increased from $4,520M in YTD 2024
- Operating Income (Q3 2025): $161M — Decreased from $218M in Q3 2024
- Net Income per Diluted Share (Q3 2025): $0.37 — Decreased from $0.49 in Q3 2024
- Total Equity (Deficit) (Nov 1, 2025): $1,592M — Negative equity position
- Amounts due under SCF program (Nov 1, 2025): $231M — Increased from $7M as of Feb 1, 2025
- Net Sales: $1.549B — Up 1.5% from $1.526B in Q2 2024
- Net Income: $64M — Down 57.9% from $152M in Q2 2024
- Diluted EPS: $0.30 — Down from $0.68 in Q2 2024
- Inventories: $977M — Up 33.1% from $734M at Feb 1, 2025
- Provision for Income Taxes: $31M — Significantly up from $1M in Q2 2024
- Operating Income: $157M — Down 14.2% from $183M in Q2 2024
- Cash and Cash Equivalents: $364M — Down from $674M at Feb 1, 2025
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Bath & Body Works, INC. (BBWI)?
Bath & Body Works, INC. has 36 recent SEC filings from Jan 2024 to Nov 2025, including 15 8-K, 9 SC 13G/A, 6 10-Q. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of BBWI filings?
Across 36 filings, the sentiment breakdown is: 3 bearish, 33 neutral. The dominant sentiment is neutral.
Where can I find Bath & Body Works, INC. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Bath & Body Works, INC. (BBWI) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Bath & Body Works, INC.?
Key financial highlights from Bath & Body Works, INC.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for BBWI?
The investment thesis for BBWI includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Bath & Body Works, INC.?
Key executives identified across Bath & Body Works, INC.'s filings include Gina Boswell, Andrew Meslow, Sarah Nash, Leslie Wexner, Daniel S. Loeb and 3 others.
What are the main risk factors for Bath & Body Works, INC. stock?
Of BBWI's 27 assessed filings, 1 were flagged high-risk, 12 medium-risk, and 14 low-risk.
What are recent predictions and forward guidance from Bath & Body Works, INC.?
Forward guidance and predictions for Bath & Body Works, INC. are extracted from SEC filings as they are enriched.